A Novel Orthotopic Mouse Model of Head and Neck Cancer and Lymph Node Metastasis

Overview

Journal Oncogenesis

Date 2013 Sep 11

PMID 24018643

Citations 21

Authors

R Masood

C Hochstim

B Cervenka

S Zu

S K Baniwal

V Patel

A Kobielak

U K Sinha

Affiliations

Soon will be listed here.

Abstract

Prognosis of head and neck squamous cell carcinoma (HNSCC) is largely determined by the extent of lymph node (LN) metastasis at diagnosis, and this appears to be controlled by cancer cell genetics. To examine the role of these genes in LN metastasis, we created a human-in-mouse orthotopic model of HNSCC and performed comparative microarray analysis of gene expression between populations of HNSCC cell lines derived before and after serial transplantation and in vivo metastasis in mice. Microarray analysis comparing the USC-HN3-GFP, USC-HN3-GFP-G1 and USC-HN3-GFP-G2 cell lines identified overexpression of genes implicated in epithelial-to- mesenchymal transition and the formation of cancer stem cells, including CAV-1, TLR-4 (Toll-like receptor 4), MMP-7 (matrix metalloproteinase 7), ALDH1A3, OCT-4 and TRIM-29. Ingenuity Pathway Analysis confirmed upregulation of respective gene signaling pathways in the USC-HN1-GFP-G2 cell line. Patient HNSCC samples from advanced stages overexpressed ALDH1A3, CAV-1 and MMP-7. Our results show that CAV-1, TLR-4, MMP-7, ALDH1A3, OCT-4 and TRIM-29 have increased expression in HNSCC cells selected for an enhanced metastatic phenotype and suggest that these genes may have an important role in the metastatic potential of HNSCC cells. Inhibition of these genes may therefore have prognostic and therapeutic utility in HNSCC.

Citing Articles

Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.

Hyeon D, Nam D, Shin H, Jeong J, Jung E, Cho S Mol Cancer. 2025; 24(1):77.

PMID: 40087745 DOI: 10.1186/s12943-025-02256-3.

TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond.

Wu Q, Nandi D, Sharma D Cancer Metastasis Rev. 2024; 44(1):16.

PMID: 39644332 PMC: 11625080. DOI: 10.1007/s10555-024-10226-2.

TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer.

Chiang D, Yap B Curr Issues Mol Biol. 2024; 46(10):10745-10761.

PMID: 39451518 PMC: 11506413. DOI: 10.3390/cimb46100638.

Diffuse reflectance spectroscopy for optical characterizations of orthotopic head and neck cancer models .

Saha P, Yan J, Zhu C Biomed Opt Express. 2024; 15(7):4176-4189.

PMID: 39022549 PMC: 11249676. DOI: 10.1364/BOE.528608.

Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data.

Zohud O, Lone I, Nashef A, Iraqi F Animal Model Exp Med. 2023; 6(6):537-558.

PMID: 38129938 PMC: 10757216. DOI: 10.1002/ame2.12367.

References

Szczepanski M, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A . Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res. 2009; 69(7):3105-13. PMC: 3708458. DOI: 10.1158/0008-5472.CAN-08-3838. View

Zhou Z, Yang G, Zhou J, Yu M . Significance of TRIM29 and β-catenin expression in non-small-cell lung cancer. J Chin Med Assoc. 2012; 75(6):269-74. DOI: 10.1016/j.jcma.2012.04.015. View

Hecht S . Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003; 3(10):733-44. DOI: 10.1038/nrc1190. View

Luo Y, Dallaglio K, Chen Y, Robinson W, Robinson S, McCarter M . ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012; 30(10):2100-13. PMC: 3448863. DOI: 10.1002/stem.1193. View

Chang C, Chien Y, Lu K, Chang S, Chou Y, Huang C . Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun. 2011; 415(2):245-51. DOI: 10.1016/j.bbrc.2011.10.024. View

Rosano L, Cianfrocca R, Spinella F, Di Castro V, Nicotra M, Lucidi A . Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res. 2011; 17(8):2350-60. DOI: 10.1158/1078-0432.CCR-10-2325. View

Zuo J, Zhu W, Li M, Li X, Yi H, Zeng G . Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem. 2011; 112(9):2508-17. DOI: 10.1002/jcb.23175. View

Sano D, Myers J . Xenograft models of head and neck cancers. Head Neck Oncol. 2009; 1:32. PMC: 2737672. DOI: 10.1186/1758-3284-1-32. View

Hung K, Lin S, Liu C, Chang C, Chang K, Kao S . The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med. 2003; 32(8):461-7. DOI: 10.1034/j.1600-0714.2003.00185.x. View

10.

Hwang W, Yang M, Tsai M, Lan H, Su S, Chang S . SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology. 2011; 141(1):279-91, 291.e1-5. DOI: 10.1053/j.gastro.2011.04.008. View

11.

Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y . Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2005; 231(1):20-7. DOI: 10.1177/153537020623100103. View

12.

Wang L, Heidt D, Lee C, Yang H, Logsdon C, Zhang L . Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell. 2009; 15(3):207-19. PMC: 2673547. DOI: 10.1016/j.ccr.2009.01.018. View

13.

GOLDBERG H, Lockwood S, Wyatt S, Crossett L . Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer. 1994; 74(2):565-72. DOI: 10.1002/1097-0142(19940715)74:2<565::aid-cncr2820740206>3.0.co;2-i. View

14.

Chute J, Muramoto G, Whitesides J, Colvin M, Safi R, Chao N . Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci U S A. 2006; 103(31):11707-12. PMC: 1544234. DOI: 10.1073/pnas.0603806103. View

15.

Wang W, Chen P, Wang H, Liang W, Su Y . Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis. 2006; 27(5):1113-20. DOI: 10.1093/carcin/bgi351. View

16.

Stransky N, Egloff A, Tward A, Kostic A, Cibulskis K, Sivachenko A . The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046):1157-60. PMC: 3415217. DOI: 10.1126/science.1208130. View

17.

Jing Y, Han Z, Sun K, Zhang S, Hou J, Liu Y . Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med. 2012; 10:98. PMC: 3482562. DOI: 10.1186/1741-7015-10-98. View

18.

Walton K, Cole A, Yeh M, Subbanagounder G, Krutzik S, Modlin R . Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol. 2003; 23(7):1197-203. DOI: 10.1161/01.ATV.0000079340.80744.B8. View

19.

Zhang X, Su L, Pirani A, Wu H, Zhang H, Shin D . Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis. Clin Exp Metastasis. 2006; 23(3-4):209-22. DOI: 10.1007/s10585-006-9031-0. View

20.

Vermorken J, Herbst R, Leon X, Amellal N, Baselga J . Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies. Cancer. 2008; 112(12):2710-9. DOI: 10.1002/cncr.23442. View